Impact of prestorage leucoreduction of autologous whole blood on length of hospital stay with a subgroup analysis in bilateral hip arthroplasty

Although prestorage leucoreduction (LR) of blood components for transfusion has gained favour around the world, evidence of its beneficial clinical effects is ambiguous.

[1]  A. Clark,et al.  Macrophage responses to lipopolysaccharide are modulated by a feedback loop involving prostaglandin E2, dual specificity phosphatase 1 and tristetraprolin , 2017, Scientific Reports.

[2]  M. Akagi,et al.  Incidence of venous thromboembolism and bleeding events in patients with lower extremity orthopedic surgery: a retrospective analysis of a Japanese healthcare database , 2017, Journal of Orthopaedic Surgery and Research.

[3]  G. Marano,et al.  Leucoreduction of blood components: an effective way to increase blood safety? , 2016, Blood transfusion = Trasfusione del sangue.

[4]  I. Arévalo-Rodriguez,et al.  Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion. , 2015, The Cochrane database of systematic reviews.

[5]  S. Laradi,et al.  The role of microparticles in inflammation and transfusion: A concise review. , 2015, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[6]  O. Garraud,et al.  An overview of the role of microparticles/microvesicles in blood components: Are they clinically beneficial or harmful? , 2015, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[7]  M. Satake,et al.  Estimation of the infectious viral load required for transfusion‐transmitted human T‐lymphotropic virus type 1 infection (TT‐HTLV‐1) and of the effectiveness of leukocyte reduction in preventing TT‐HTLV‐1 , 2015, Vox sanguinis.

[8]  Wei-guo Zhang,et al.  Risk factors for deep vein thrombosis after orthopedic surgery and the diagnostic value of D-dimer. , 2015, Annals of vascular surgery.

[9]  K. Tsuzaki,et al.  [Incidence and characteristics of perioperative pulmonary thromboembolism in Japan from 2009 through 2011 -the results of perioperative pulmonary thromboembolism research by the Japanese society of anesthesiologists (JSA-PTE research) --]. , 2013, Masui. The Japanese journal of anesthesiology.

[10]  W. Jy,et al.  Microparticles in stored red blood cells as potential mediators of transfusion complications , 2011, Transfusion.

[11]  H. Ohto,et al.  EFFECT OF PRE-STORAGE LEUKOREDUCED AUTOLOGOUS BLOOD ON EDEMA AND LEG PAIN AFTER ORTHOPEDIC SURGERY , 2011 .

[12]  Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[13]  N. Lion,et al.  Microparticles in stored red blood cells: submicron clotting bombs? , 2010, Blood transfusion = Trasfusione del sangue.

[14]  H. Ohto,et al.  Preventing platelet-derived microparticle formation--and possible side effects-with prestorage leukofiltration of whole blood. , 2010, Archives of pathology & laboratory medicine.

[15]  H. Ohto,et al.  Significance of pre‐storage leucoreduction for autologous blood , 2009, Vox sanguinis.

[16]  T. Frietsch,et al.  Leukodepletion of autologous whole blood has no impact on perioperative infection rate and length of hospital stay , 2008, Transfusion.

[17]  L. Van De Watering.  The intention‐to‐treat principle in clinical trials and meta‐analyses of leukoreduced blood transfusions in surgical patients , 2007, Transfusion.

[18]  M. Colonna,et al.  Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor‐β1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA‐I , 2007, Transfusion.

[19]  G. Lyman,et al.  The intention‐to‐treat principle in clinical trials and meta‐analyses of leukoreduced blood transfusions in surgical patients , 2007, Transfusion.

[20]  D. Fergusson,et al.  Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[21]  Makoto Ito,et al.  [Incidence and characteristics of perioperative pulmonary thromboembolism in Japan]. , 2004, Masui. The Japanese journal of anesthesiology.

[22]  D. Coyle,et al.  Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. , 2003, JAMA.

[23]  F. Fowkes,et al.  Incidence of diagnosed deep vein thrombosis in the general population: systematic review. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[24]  H. Ikeda,et al.  EFFECT OF ANTI‑COAGULANTS ON PRESTORAGE LEUKOCYTE‑REDUCED RED CELL COMPONENTS:CPD VS. ACD‑A SOLUTION , 2001 .

[25]  P. Bridenbaugh.  Complications , 2018, Regional Anesthesia & Pain Medicine.